Pharma channel feed

Ky­owa Kirin bol­sters cam­paign to close racial dis­par­i­ty gap in rare ‘lym­phoma of the skin’

3 years ago
Marketing

Form 483 re­veals spore con­t­a­m­i­na­tion at a South Ko­re­an man­u­fac­tur­ing site last year

3 years ago
FDA+
Manufacturing

Good Ther­a­peu­tics sells PD-1 IL-2 pro­gram to Roche for $250M and will march on with a sim­i­lar name, but in Latin

3 years ago
Deals

Over $50M in fed­er­al funds are go­ing to Vir­ginia’s phar­ma man­u­fac­tur­ing sec­tor

3 years ago
Financing
Manufacturing

Bay­er agrees to pay $40M to set­tle kick­back, safe­ty claims sparked by whistle­blow­er

3 years ago
Law

Boehringer In­gel­heim preps FDA sub­mis­sion with new da­ta in rare pe­di­atric lung dis­ease

3 years ago
R&D

Sun Phar­ma en­lists der­ma­tol­ogy HCPs to talk about per­son­al ac­ne ex­pe­ri­ences in new cam­paign

3 years ago
Marketing

As­traZeneca ex­pands its block­buster Imfinzi fran­chise with new ap­proval in bil­iary tract can­cer

3 years ago
FDA+

For­mer con­tract man­u­fac­tur­er CEO sen­tenced to prison for ship­ping con­t­a­m­i­nat­ed drugs to chil­dren's hos­pi­tals

3 years ago
Manufacturing
Law

Mar­ket­ingRx roundup: Pfiz­er boosts sci­ence with pop cul­ture takes on Face­book; BMS, Jazz de­but new SU2C teams

3 years ago
Marketing

Noth­ing to laugh about: What hap­pened to hu­mor in phar­ma ad­ver­tis­ing?

3 years ago
Marketing

Alvotech fails pre-ap­proval in­spec­tion for its pro­posed Hu­mi­ra in­ter­change­able biosim­i­lar

3 years ago
FDA+

Up­dat­ed: EU swats down Il­lu­mi­na's $8B Grail ac­qui­si­tion days af­ter FTC lost an­titrust case

3 years ago
Deals

FDA again finds Amy­lyx's ALS da­ta lack­ing ahead of un­usu­al sec­ond ad­comm, while stress­ing dire need for treat­ments

3 years ago
FDA+

FDA ex­pands ap­proval for Ver­tex's CF drug Orkam­bi to in­fants un­der two years of age

3 years ago
FDA+

Lead­ing health­care agency notch­es dou­ble-dig­it growth for first half, dri­ven by dig­i­tal shifts and full pipelines

3 years ago
Marketing

Mer­ck spells out ac­cess, en­vi­ron­men­tal goals in lat­est ESG re­port

3 years ago
Marketing

Am­neal asks FDA to ap­prove an­oth­er new for­mu­la­tion of Parkin­son’s com­bo drug 

3 years ago
FDA+

Azu­ri­ty Phar­ma­ceu­ti­cals con­tin­ues its win streak as it bags an­oth­er ap­proval from the FDA

3 years ago
FDA+

Top Boehringer In­gel­heim drug gets FDA ap­proval in rare skin dis­ease

3 years ago
FDA+

Pfiz­er reshuf­fles top lead­er­ship to hone com­mer­cial strat­e­gy, leav­ing room for new rare dis­ease chief

3 years ago
People

Spe­cial­ty drug mar­ket jumps, dri­ven by new users — not high­er price tags — and more biosim­i­lar up­take

3 years ago
Marketing

Il­lu­mi­na pre­vails over FTC's chal­lenge of $8B Grail buy­out

3 years ago
Deals
Law

Fol­low­ing FDA, CHMP gives thumbs-up on Pfiz­er, BioN­Tech Omi­cron boost­er

3 years ago
Coronavirus
First page Previous page 175176177178179180181 Next page Last page
A service from the Financial Times